Products Categories
| CAS No.: | 1759-53-1 |
|---|---|
| Name: | Cyclopropanecarboxylic acid |
| Article Data: | 75 |
| Cas Database | |
| Molecular Structure: | |
|
|
|
| Formula: | C4H6O2 |
| Molecular Weight: | 86.0904 |
| Synonyms: | Carboxycyclopropane;Cyclopropionic acid;Cyclopropylcarboxylic acid;NSC 1112;Cyclopropyl Carboxylic Acid; |
| EINECS: | 217-162-5 |
| Density: | 1.314 g/cm3 |
| Melting Point: | 14-17 °C(lit.) |
| Boiling Point: | 183 °C at 760 mmHg |
| Flash Point: | 71.7 °C |
| Appearance: | clear colourless to light yellow liquid |
| Hazard Symbols: |
 C, Xi
|
| Risk Codes: | 22-34 |
| Safety: | 26-27-36/37/39-45 |
| Transport Information: | UN 3265 8/PG 2 |
| PSA: | 37.30000 |
| LogP: | 0.48100 |
- 1759-55-3Cyclopropanecarboxamide,2,2-dimethyl-
- 175965-82-9Pyridine,4-ethoxy-2-fluoro-
- 175965-83-0Pyridine,2-fluoro-4-methoxy-
- 17596-79-1Benzeneethanamine, b-methyl-, (bS)-
- 175968-39-5Benzoic acid,2,3-difluoro-4-hydroxy-
- 1759-71-31,2-Cyclohexanediol,1,2-diacetate, (1R,2R)-rel-
- 17597-70-5Cyclopenta[ef]heptalene,3,5,8,10-tetramethyl-
- 175978-56-0Methyl-azido-2-deoxy-3-O-(phenylmethyl)-alpha-D-glucopyranoside6-acetate
- 1759-81-5Cyclopentene, 4-methyl-
- 17598-15-1(2-Hydroxyethyl)ammonium hydrogen tartrate
- 30923-69-4
1‐cyclopropyl‐4,4,4‐trifluorobutane‐1,3‐dione
- 1759-53-1
cyclopropanecarboxylic acid
| Conditions | Yield |
|---|---|
| With oxygen; sodium hydrogencarbonate In acetonitrile for 4h; Molecular sieve; Irradiation; | 98% |
- 1427519-95-6
(3S,4S)-4-(N-allyl-4-methylphenylsulfonamido)-1,3-diphenylhept-1-yn-3-yl cyclopropanecarboxylate
A
- 1427520-28-2
((3R,6S)-3-methyl-5-phenyl-6-propyl-1-tosyl-1,2,3,6-tetrahydropyridin-4-yl)(phenyl)methanone
B
- 1759-53-1
cyclopropanecarboxylic acid
| Conditions | Yield |
|---|---|
| With Echavarren's catalyst; water In 1,2-dichloro-ethane at 80℃; for 24h; Inert atmosphere; stereoselective reaction; | A 97% B n/a |
| Conditions | Yield |
|---|---|
| Stage #1: 2,3-dibromopropionic acid; acetyl chloride With copper(l) chloride; zinc In diethyl ether at 10 - 20℃; for 11h; Inert atmosphere; Stage #2: With Methylenetriphenylphosphorane In diethyl ether Temperature; Solvent; Concentration; | 96% |
- 1427519-96-7
(3S,4S)-4-(N-allyl-4-methylphenylsulfonamido)-6-methyl-1,3-diphenylhept-1-yn-3-yl cyclopropanecarboxylate
A
- 1427520-27-1
((3R,6S)-6-isobutyl-3-methyl-5-phenyl-1-tosyl-1,2,3,6-tetrahydropyridin-4-yl)(phenyl)methanone
B
- 1759-53-1
cyclopropanecarboxylic acid
| Conditions | Yield |
|---|---|
| With Echavarren's catalyst; water In 1,2-dichloro-ethane at 80℃; for 24h; Inert atmosphere; stereoselective reaction; | A 94% B n/a |
A
- 71019-06-2
2-fluoro-1-tetralone
B
- 1759-53-1
cyclopropanecarboxylic acid
| Conditions | Yield |
|---|---|
| With Selectfluor In water; acetonitrile at 20℃; | A 93% B n/a |
| Conditions | Yield |
|---|---|
| With water; nitrile hydratase SP361 at 30℃; for 24h; in potassium phosphate buffer (pH = 7); | 92% |
| With phosphoric acid; phosphorus pentoxide at 140℃; | |
| With sodium hydroxide | |
| With potassium hydroxide | |
| In sodium hydroxide |
| Conditions | Yield |
|---|---|
| 90% |
- 1427520-01-1
(3S,4S)-4-(N-allyl-4-methylphenylsulfonamido)-6-(methylsulfonyl)-1,3-diphenylhex-1-yn-3-yl cyclopropanecarboxylate
A
- 1427520-30-6
((3R,6S)-3-methyl-6-(2-(methylsulfonyl)ethyl)-5-phenyl-1-tosyl-1,2,3,6-tetrahydropyridin-4-yl)(phenyl)methanone
B
- 1759-53-1
cyclopropanecarboxylic acid
| Conditions | Yield |
|---|---|
| With Echavarren's catalyst; water In 1,2-dichloro-ethane at 80℃; for 24h; Inert atmosphere; stereoselective reaction; | A 87% B n/a |
| Conditions | Yield |
|---|---|
| With 2-mesityl-6,7-dihydro-5H-pyrrolo[2,1-c][1,2,4]triazol-2-ium tetrafluoroborate; 1,3,4,6,7,8-hexahydro-2H-pyrimido[1,2-a]pyrimidine In acetonitrile at 20℃; | 80% |
| With Iron(III) nitrate nonahydrate; oxygen In acetonitrile at 25℃; under 760.051 Torr; for 12h; Catalytic behavior; Reagent/catalyst; Schlenk technique; | 80% |
| With Oxone; ethylenediaminetetraacetic acid; sodium hydrogencarbonate In water; acetone at 22℃; for 3h; Oxidation; | 71% |
| With air at 21℃; for 2h; |
- 85696-55-5
tert-butyl(cyclopropylmethoxy)dimethylsilane
- 1759-53-1
cyclopropanecarboxylic acid
| Conditions | Yield |
|---|---|
| With ruthenium(IV) oxide; sodium periodate | 78% |
- 26386-88-9Phosphorazidic acid,diphenyl ester
- 485-47-2Ninhydrin hydrate
- 109-43-3Dibutyl sebacate
- 112811-72-01-Cyclopropyl-6,7-difluoro-1,4-dihydro-8-methoxy-4-oxo-3-quinolinecarboxylic acid
- 850649-62-6Alogliptin benzoate
- 593-85-1Guanidine carbonate
- 119-47-1Phenol,2,2'-methylenebis[6-(1,1-dimethylethyl)-4-methyl-
- 73590-85-91H-Benzimidazole,6-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]thio]-
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
What can I do for you?
Get Best Price
Specification
The Cyclopropanecarboxylic acid, with its CAS registry number 1759-53-1, is a kind of clear colourless to light yellow liquid. This is insoluble in water while soluble in ethyl acetate and ether. As to its usage, it is usually applied as the intermediate of plant growth regulator trinexapac-ethyl and also as the pharmaceutic intermediates. Besides, its product categories are including Pharmaceutical Intermediates; Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts; Cyclopropanes; Simple 3-Membered Ring Compounds.
The characteristics of this chemical are as follows: (1)ACD/LogP: 0.08; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): -0.72; (4)ACD/LogD (pH 7.4): -2.51; (5)ACD/BCF (pH 5.5): 1; (6)ACD/BCF (pH 7.4): 1; (7)ACD/KOC (pH 5.5): 4.2; (8)ACD/KOC (pH 7.4): 1; (9)#H bond acceptors: 2; (10)#H bond donors: 1; (11)#Freely Rotating Bonds: 1; (12)Polar Surface Area: 26.3; (13)Index of Refraction: 1.521; (14)Molar Refractivity: 19.94 cm3; (15)Molar Volume: 65.4 cm3; (16)Polarizability: 7.9×10-24 cm3; (17)Surface Tension: 57.9 dyne/cm; (18)Density: 1.314 g/cm3; (19)Flash Point: 71.7 °C; (20)Enthalpy of Vaporization: 46.22 kJ/mol; (21)Boiling Point: 183 °C at 760 mmHg; (22)Vapour Pressure: 0.362 mmHg at 25°C; (23)Exact Mass: 86.036779; (24)MonoIsotopic Mass: 86.036779; (25)Topological Polar Surface Area: 37.3; (26)Heavy Atom Count: 6; (27)Complexity: 73.6.
Production method of this chemical: Cyclopropanecarbonitrile could react to produce cyclopropanecarboxylic acid. This reaction could happen in the presence of the reagent of aq. NaOH solution.
.jpg)
Use of this chemical: Cyclopropanecarboxylic acid could react to produce cyclopropylmethanol. This reaction could happen in the presence of the reagent of lithium aluminum hydride.
.jpg)
When you are dealing with this chemical, you should be very cautious. For one thing, it is irritant which may cause inflammation to the skin or other mucous membranes. And it may causes burns and it will be dangerous if swallowed. For another thing, it is corrosive which may destroy living tissue on contact. Therefore, you should wear suitable protective clothing, gloves and eye/face protection. If in case of contact with eyes, rinse immediately with plenty of water and seek medical advice, and if in case of accident or if you feel unwell seek medical advice immediately (show the label where possible). Besides, take off immediately all contaminated clothing when contact.
In addition, you could convert the following datas into the molecular structure:
(1)Canonical SMILES: C1CC1C(=O)O
(2)InChI: InChI=1S/C4H6O2/c5-4(6)3-1-2-3/h3H,1-2H2,(H,5,6)
(3)InChIKey: YMGUBTXCNDTFJI-UHFFFAOYSA-N
Below are the toxicity information of this chemical:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 172mg/kg (172mg/kg) | Journal of Pharmacy and Pharmacology. Vol. 21, Pg. 85, 1969. | |
| mouse | LD50 | intravenous | 180mg/kg (180mg/kg) | U.S. Army Armament Research & Development Command, Chemical Systems Laboratory, NIOSH Exchange Chemicals. Vol. NX#03926, | |
| mouse | LD50 | subcutaneous | 172mg/kg (172mg/kg) | Journal of Pharmacy and Pharmacology. Vol. 21, Pg. 85, 1969. |